OVERVIEW

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials! is organized by Physicians' Education Resource, LLC (PER).

Release Date: June 4, 2022
Expiration Date: June 4, 2023

Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Determine actionable biomarkers that are key to informing clinical decision-making in the management of advanced forms of NSCLC
• Explain the role of testing and methods to facilitate the application of diagnostic approaches in NSCLC treatment settings
• Describe efficacy and safety results from investigations that utilized actionable biomarkers to personalize care among patients with NSCLC
• Evaluate emerging therapeutic targets and biomarker-driven strategies undergoing late-stage evaluation for use among patients with advanced NSCLC

Additional details will be posted as soon as information is available.